To determine the degree to which the breast cancer cell lines MCF-7 and MDA-MB-231 responded to the LPS treatment, we treated these cells with LPS and measured the expressions of the COX-2 and IL-6 genes in both cell lines. The gene discussed is PTGS2; the disease is breast carcinoma.